Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
15,085 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00030173 | A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors | completed | Phase 1 | 45 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 8, 2009 | clinicaltrials |
| NCT00559429 | Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer(Tax-Sam) | completed | Phase 1 | 13 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 17, 2008 |
| clinicaltrials |
| NCT00157703 | G207 Followed by Radiation Therapy in Malignant Glioma | completed | Phase 1 | 9 | MediGeneINDUSTRY | 1 | Dec 16, 2008 | clinicaltrials |
| NCT00264472 | A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors | suspended | Phase 1 | 60 | Adherex Technologies, Inc.INDUSTRY | 1 | Dec 15, 2008 | clinicaltrials |
| NCT00319683 | A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma | terminated | Phase 1 / Phase 2 | — | Adherex Technologies, Inc.INDUSTRY | 3 | Dec 15, 2008 | clinicaltrials |
| NCT00806728 | Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease | completed | Phase 1 | 17 | MedImmune LLCINDUSTRY | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00088088 | STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 86 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Dec 4, 2008 | clinicaltrials |
| NCT00088101 | STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors | completed | Phase 1 | 42 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Dec 4, 2008 | clinicaltrials |
| NCT00421512 | A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients | completed | Phase 1 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 11, 2008 | clinicaltrials |
| NCT00712504 | Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer | completed | Phase 1 | 49 | PfizerINDUSTRY | 1 | Nov 11, 2008 | clinicaltrials |
| NCT00753480 | A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | suspended | Phase 1 | 56 | Genentech, Inc.INDUSTRY | 1 | Nov 7, 2008 | clinicaltrials |
| NCT00207103 | MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 68 | Bristol-Myers SquibbINDUSTRY | 4 | Nov 4, 2008 | clinicaltrials |
| NCT00783588 | A Phase I Extension Trial of Repeated Infusions of ISF35 | completed | Phase 1 | 4 | Memgen, LLCINDUSTRY | 1 | Oct 31, 2008 | clinicaltrials |
| NCT00352742 | A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma | terminated | Phase 1 / Phase 2 | 46 | AttenuonINDUSTRY | 1 | Oct 28, 2008 | clinicaltrials |
| NCT00091689 | Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions | completed | Phase 1 | — | PfizerINDUSTRY | 1 | Oct 27, 2008 | clinicaltrials |
| NCT00316511 | Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma | completed | Phase 1 | 21 | Agenus Inc.INDUSTRY | 1 | Oct 27, 2008 | clinicaltrials |
| NCT00779883 | A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35) | completed | Phase 1 | 9 | Memgen, LLCINDUSTRY | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00161590 | Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma | completed | Phase 1 | — | Weill Medical College of Cornell UniversityOTHER | 1 | Oct 22, 2008 | clinicaltrials |
| NCT00085878 | Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors | completed | Phase 1 | 25 | GlaxoSmithKlineINDUSTRY | 1 | Oct 16, 2008 | clinicaltrials |
| NCT00119171 | Ispinesib In Combination With Capecitabine In Patients With Solid Tumors | completed | Phase 1 | 30 | GlaxoSmithKlineINDUSTRY | 1 | Oct 16, 2008 | clinicaltrials |
| NCT00136513 | SB-743921 In Patients With Solid Tumors | completed | Phase 1 | 30 | GlaxoSmithKlineINDUSTRY | 1 | Oct 16, 2008 | clinicaltrials |
| NCT00085904 | Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas | completed | Phase 1 | 12 | GlaxoSmithKlineINDUSTRY | 1 | Oct 13, 2008 | clinicaltrials |
| NCT00027131 | Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70 | terminated | Phase 1 / Phase 2 | 15 | UConn HealthOTHER | 1 | Oct 8, 2008 | clinicaltrials |
| NCT00109655 | Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure | unknown | Phase 1 | 75 | Cell GenesysINDUSTRY | 2 | Oct 3, 2008 | clinicaltrials |
| NCT00641160 | Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies | unknown | Phase 1 | 12 | Metronome TherapeuticsINDUSTRY | 1 | Sep 26, 2008 | clinicaltrials |
| NCT00222443 | Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy | completed | Phase 1 | 40 | University of OklahomaOTHER | 1 | Sep 22, 2008 | clinicaltrials |
| NCT00328432 | A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy | completed | Phase 1 | 100 | University of KansasOTHER | 1 | Sep 17, 2008 | clinicaltrials |
| NCT00290004 | Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | completed | Phase 1 / Phase 2 | 35 | Pharmacyclics LLC.INDUSTRY | 1 | Sep 11, 2008 | clinicaltrials |
| NCT00347971 | Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma | completed | Phase 1 | 23 | ZymoGeneticsINDUSTRY | 1 | Sep 5, 2008 | clinicaltrials |
| NCT00415155 | A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma | withdrawn | Phase 1 / Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 4 | Aug 29, 2008 | clinicaltrials |
| NCT00061035 | Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma | completed | Phase 1 | 18 | Cosmo BioscienceINDUSTRY | 1 | Aug 28, 2008 | clinicaltrials |
| NCT00147485 | A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer | terminated | Phase 1 | 37 | PfizerINDUSTRY | 1 | Aug 18, 2008 | clinicaltrials |
| NCT00350831 | Study of XL820 Given Orally Daily to Subjects With Solid Tumors | completed | Phase 1 | 30 | ExelixisINDUSTRY | 1 | Aug 18, 2008 | clinicaltrials |
| NCT00003001 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 63 | Stony Brook UniversityOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00003705 | BMS-184476 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | San Antonio Cancer InstituteOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00014521 | Karenitecin in Treating Patients With Recurrent Malignant Glioma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00043095 | BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00045604 | Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00100958 | Indole-3-Carbinol in Preventing Cancer in Healthy Participants | completed | Phase 1 | — | University of KansasOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00606879 | Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors | terminated | Phase 1 | 46 | SGX Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00607399 | Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors | terminated | Phase 1 | 46 | SGX Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00406939 | Vector Delivery of the IL-12 Gene in Men With Prostate Cancer | completed | Phase 1 | 4 | Baylor College of MedicineOTHER | 1 | Jul 10, 2008 | clinicaltrials |
| NCT00553748 | Phase I, Open Label, Single Center Safety Study of [F-18]FLT | completed | Phase 1 | 11 | Siemens Molecular ImagingINDUSTRY | 1 | Jul 3, 2008 | clinicaltrials |
| NCT00387062 | Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment | completed | Phase 1 | 50 | Posit Science CorporationINDUSTRY | 1 | Jun 24, 2008 | clinicaltrials |
| NCT00298779 | Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma. | completed | Phase 1 | 20 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 6, 2008 | clinicaltrials |
| NCT00129571 | Study of XL820 in Adults With Solid Tumors | completed | Phase 1 | — | ExelixisINDUSTRY | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00139243 | Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00234481 | Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia | terminated | Phase 1 | — | ExelixisINDUSTRY | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00460278 | Study of XL418 in Adults With Solid Tumors | suspended | Phase 1 | 63 | ExelixisINDUSTRY | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00530101 | The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity | completed | Phase 1 | 3 | University of MiamiOTHER | 1 | Jun 4, 2008 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials